Provings

G. Dominici, F. Allegri, M. C. Andreotti, M. Impallomeni, C. Marcolin, I. Mariani, E.Tonini, R. Pomposelli

◊ PROVING OF COLIBACILLINUM
Homeopathic School of Verona 2011

 Colibacillinum is a relatively unknown nosode. The Homeopathic School of Verona organized a proving of the homeopathic drug which was conducted between February and May 2011. The subjects were recruited from students and teachers of the school: 15 provers, 6 supervisors, 1 coordinator and 1 director. The proving consisted of a triple blind test with a 20% placebo control sample. 30CH (6), 200CH (3) and MK (3) potencies were used together with a placebo (3). The observation period lasted 30 days. The article describes the symptoms experienced (pathogenesis). The results show that  Colibacillinum can be prescribed as a homeopathic medicine.

HOMEOPATHY (2006) 95, 123-130
G. Dominici, P. Bellavite, C. di Stanislao, P. Gulia, G. Pitari

◊ DOUBLE-BLIND, PLACEBO-CONTROLLED HOMEOPATHIC PATHOGENETIC TRIALS: SYMPTOM COLLECTION AND ANALYSIS

Homeopathic pathogenetic trials (provings) are fundamental to homeopathy. Since most of the data from available provings have not been statistically evaluated, it is unclear how specific reported symptoms are and how they differ from those reported by people taking placebo. Method: We combine and analyse data from two different homeopathic pathogenic trials—including 10 and 11 provers, respectively, and both including 30% placebo—to test the null hypothesis that there is no significant difference between the number of symptoms in placebo and verum groups. Results: The principal results were: _ Placebo reported less symptoms than verum groups. _ Symptom distribution according to predefined classes (common symptoms increased in intensity and/or duration-, cured, old, new and exceptional) was statistically different between placebo and verum group at a high level of significance (Po0.001). Compared to verum, placebo provers reported less new and old but more common (increased in duration or intensity) symptoms. _ Within repertory categories, other differences were detected. _ The two groups differ in terms of the duration of each symptom and kinetics of symptoms: most symptoms were more persistent in verum than in placebo groups and verum provers recorded a decreasing number of symptoms with time. Placebo provers did not show such a temporal pattern. Conclusions: If confirmed by other studies these results would demonstrate the non equivalence between homeopathic medicines in high dilution and placebo and contribute to the improvement of proving methodology and evaluation.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

63rd CONGRESS OF THE LIGA MEDICORUM HOMEOPATICA INTERNATIONALIS (LMHI)
May 20-24 2008, Oostende (Belgium)
G. Dominici, MD - Mauro Dodesini, DVM

◊ HYDROGENIUM PEROXIDATUM - H2O2
Proving results and clinical use of Hydrogenium peroxide in humans and animals

The homeopathic proving of Hydrogenium peroxidatum (H2O2) was carried out between February and June 2004 using a double-blind, randomized, placebo controlled trial [1,2]. The elaboration of the data turned out to be demanding, due to the slow development of symptomatology in the provers. Hydrogenium peroxidatum was administered in 30 CH potency. Two provers continued the trial receiving a 200 K potency. The present paper shows proving results and clinical use of Hydrogenium peroxidatum in humans and animals. Clinical results underlined the ability of this homeopathic remedy to improve and even to recover functional and structural intellectual deficit. The first encouraging results show that the remedy could be very important in the terapy of degenerative diseases of CNS, which are currently strongly increasing. In this case the homeopathic terapy might be useful where traditional medicine have no chances. AWARD FOR BEST PRESENTATION OF THE CONGRESS
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

1 2